Back to Search Start Over

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Authors :
Giandomenico Roviello
Sebastiano Buti
Carlo Cattrini
Alessia Mennitto
Carlo Messina
Chiara Airoldi
Gianmarco Vannini
Melissa Bersanelli
Source :
Therapeutic Advances in Urology, Vol 13 (2021)
Publication Year :
2021
Publisher :
SAGE Publishing, 2021.

Details

Language :
English
ISSN :
17562880 and 17562872
Volume :
13
Database :
Directory of Open Access Journals
Journal :
Therapeutic Advances in Urology
Publication Type :
Academic Journal
Accession number :
edsdoj.188809f92a4b473e87c21baf2b6567bc
Document Type :
article
Full Text :
https://doi.org/10.1177/17562872211029784